DNA aptamers that inhibit binding to human interleukin-17A and interleukin-20

Ali Parvez1, Kirsten Sully1, Dana A Baum1

  • 1Department of Chemistry, Saint Louis University 3501 Laclede Avenue St. Louis MO USA dana.baum@slu.edu.

RSC Advances
|April 22, 2026
PubMed
Summary

Researchers developed DNA aptamers targeting inflammatory cytokines interleukin-17 (IL-17) and interleukin-20 (IL-20). These aptamers are valuable tools for understanding autoimmune diseases and developing new therapies.